Adir Et Compagnie

Les Laboratoires Servier

Adir Et Cie

Guillaume Le Baut

Pierre Renard

Daniel-Henri Caignard

Gerard Adam

Sylvie Robert-Piessard

Jean-Michel Robert

Jean-Paul Babingui

Muriel Duflos

Jean-Daniel Brion

Jean-Francois Renaud De La Faverie

Jacqueline Courant

Genevieve Seurre

Claudie Moulin

Odile Rideau

Lucien Welin

Larbi Belachmi

Patrick Ducrey

Sylvie Piessard-Robert

Alain Pierre

Ghanem Atassi

Jacqueline Bonnet

G Erard Adam

Massimo Sabatini

Jean-Guy Bizot-Espiard

Claude Cudennec

Charles Tordjman

Dominique Manechez

Guillaume Poissonnet

Lucy De Montarby

Elisabeth Scalbert

Marie-Renee Nourrisson

Ludovic Durand

Marie-Ren&eacute;e Nourrisson

Alain Tonnerre

Timothee Muller

Jean-Francois R De La Faverie

Francoise Zammatio

Jean D Brion

jean-Francois Renaud De La Faverle

Jean-Guy Bizot Espiard

Derivatives of 3-imino-1,2-dithioles, method for producing them and pharmaceutical compositions containing the same

A compound of formula (I): ##STR1## in which: R.sub.1 represents alkyl,

Benzopyran compounds

A compound selected from those of formula (I): ##STR1## where m is equal to 0 or 1 and Het, A, X, R,R.sub.1, R.sub.2, R.sub.3, R.sub.4 and the ring ##STR2## are defined in the description, and a medicinal product comprising the same for treating an inflammatory disorder.

N-pyridyl carboxamides and derivatives

A compound selected from those of formula (I): ##STR1## where m is equal to 0 or 1 and

A method of treating a mammal afflicted with a disorder associated with the Na.sup.+ -independent Cl.sup.- /HCO.sub.3 - exchanger comprising the step of administering a compound selected from those of formula (I): ##STR1## in which R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, R.sub.7, R.sub.8, R.sub.9, R.sub.10, R.sub.11 and n are as defined in the description, which is effective for alleviating the said disorder.

Use of benzopyran derivatives for the treatment of pathologies

Compounds of the general formula: ##STR1## wherein m, X, Y, A, R.sub.2 and R.sub.3 are defined in the description, and medicaments containing the same.

Alpha-amino acid compounds

Compounds of the general formula: ##STR1## wherein m, X, Y, A, R.sub.2 and R.sub.3 are defined in the description.

.alpha.-amino acid compounds

A compound of the formula (I) ##STR1## in which: R.sub.1 represents a hydrogen atom, a lower alkyl group, a hydroxy group or a lower alkoxy group,

Heterocyclic compounds: 2-styryl-4H-1-benzopyran-4-ones

A compound selected from those of formula (I): ##STR1## in which R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, R.sub.7, R.sub.8, R.sub.9 and n are as defined in the description, its optical isomers, and its addition salts thereof with a pharmaceutically-acceptable acid or base, and medicinal product containing the same for treating a mammal afflicted with a disorder connected with peroxydation processes and biosynthesis of eicosanoids.

New benzopyran compounds

A compound selected from those of formula (I): ##STR1## in which the groups R.sub.1 to R.sub.8 are as defined the description. Medicaments.

New chromene compounds having a triene side chain

The invention relates to a compound selected from those of formula (I): ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5 and X are as defined in the description, its Z and E isomers, its optical isomers, in pure form or in the form of a mixture, and its addition salts thereof with a pharmaceutically-acceptable acid or base, and medicinal products containing the same which are useful in treating a disorder resulting from or associated with peroxidation phenomena, disturbances in eicosanoid synthesis, or with platelet aggregation disorders.

New 3-(hydroxybenzylidenyl)-indolin-2-ones

A compound selected from the group consisting of those of formula I ##STR1## in which R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, R.sub.7, X and n are defined in the description, an optical isomer thereof, and an addition salt thereof with a pharmaceutically-acceptable base or acid. Medicinal product which is useful in treating or in preventing a disorder due to or linked to the phenomena of peroxidation and to the disturbance of the eicosanoid biosynthesis.

A compound selected from those of the formula I: ##STR1## in which: R.sub.1 represents hydrogen or alkyl having 1 to 3 inclusive carbon atoms,

Compounds of general formula (I): ##STR1## in which: R denotes a hydrogen atom, a halogen atom or a hydroxy, lower alkyl, lower alkyloxy, carboxyl, (lower alkyloxy)carbonyl, (lower arylalkyloxy)carbonyl, aminocarbonyl, (lower mono- or dialkyl)aminocarbonyl or (lower arylalkyl)aminocarbonyl group, an aminocarbonyl group N-substituted with a heterocyclic radical, or a thio, (lower alkyl)thio, sulfonyl or (lower alkyl)sulfonyl group,

New heteroarotinoid compounds

Growing community of inventors

Saint Sebastien Sur Loire, France

Guillaume Le Baut